JALIPTEX Trademark

Trademark Overview

On Friday, May 30, 2008, a trademark application was filed for JALIPTEX with the United States Patent and Trademark Office. The USPTO has given the JALIPTEX trademark a serial number of 77486909. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 7, 2017. This trademark is owned by AstraZeneca AB. The JALIPTEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer and diabetes
jaliptex

General Information

Serial Number77486909
Word MarkJALIPTEX
Filing DateFriday, May 30, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 7, 2017
Registration Number3839692
Registration DateTuesday, August 31, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer and diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 7, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje
SE

Trademark Events

Event DateEvent Description
Friday, April 7, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, August 31, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, June 15, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2010PUBLISHED FOR OPPOSITION
Tuesday, May 11, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 10, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 19, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 19, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 14, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 14, 2010EXAMINER'S AMENDMENT ENTERED
Wednesday, April 14, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 14, 2010EXAMINERS AMENDMENT E-MAILED
Wednesday, April 14, 2010EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 14, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 14, 2009NON-FINAL ACTION E-MAILED
Wednesday, October 14, 2009NON-FINAL ACTION WRITTEN
Wednesday, September 23, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 23, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 23, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 30, 2009NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, March 30, 2009INQUIRY TO SUSPENSION E-MAILED
Monday, March 30, 2009SUSPENSION INQUIRY WRITTEN
Wednesday, March 11, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, March 11, 2009ASSIGNED TO LIE
Thursday, September 11, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 11, 2008LETTER OF SUSPENSION E-MAILED
Thursday, September 11, 2008SUSPENSION LETTER WRITTEN
Thursday, September 11, 2008ASSIGNED TO EXAMINER
Tuesday, June 3, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

jaliptex pharmaceutical treatment preparations pain inflammation cancer diabetes systems infection respiratory